Updated Jul 16, 2026
Hawryluk P. Kent has filed 1 SEC Form 4 filing across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $798K. Lifetime open-market sales: $18K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-08 | MBX | MBX Biosciences, Inc. | S — Open-market sale | 607 | $29.54 | $18K |
| 2026-03-16 | MBX | MBX Biosciences, Inc. | P — Open-market purchase | 18.5K | $28.41 | $526K |
| 2026-02-27 | MBX | MBX Biosciences, Inc. | M — Option exercise | 28.8K | $16.00 | $460K |
| 2026-02-03 | MBX | MBX Biosciences, Inc. | A — Grant or award | 35.2K | $0.00 | |
| 2025-10-28 | MBX | MBX Biosciences, Inc. | M — Option exercise | 182.9K | $3.25 | $594K |
| 2025-10-21 | MBX | MBX Biosciences, Inc. | P — Open-market purchase | 20.0K | $13.64 | $273K |
Hawryluk P. Kent is a corporate insider — currently tracked as Insider of MBX Biosciences, Inc. (MBX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($798K) and 1 open-market sales ($18K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hawryluk P. Kent profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.